A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
Public ClinicalTrials.gov record NCT00800267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-month, Randomized, Double-masked Comparison of Fixed Combination of Latanoprost and Timolol With the Individual Components, Continuing Into a 6-month Open Label Safety Study of Fixed Combination in Patients With Glaucoma or Ocular Hypertension. A Multicenter Study in the United States
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Safety and efficacy study comparing between fixed combination latanoprost-timolol and its component parts.
Study identification
- NCT ID
- NCT00800267
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 418 participants
Conditions and interventions
Conditions
Interventions
- latanoprost 0.005% Drug
- fixed combination latanoprost-timolol Drug
- timolol 0.5% Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 1997 (Type not available)
- Primary completion
- Jun 1999 (Actual)
- Completion
- Jun 1999 (Actual)
- Last update posted
- Feb 18, 2021
1997 – 1999
United States locations
- U.S. sites
- 53
- U.S. states
- 23
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Anaheim | California | 92801 | — |
| Pfizer Investigational Site | Anaheim | California | 92807 | — |
| Pfizer Investigational Site | Sacramento | California | 95819 | — |
| Pfizer Investigational Site | Sacramento | California | 95823 | — |
| Pfizer Investigational Site | San Francisco | California | 94115 | — |
| Pfizer Investigational Site | Boulder | Colorado | 80304-3573 | — |
| Pfizer Investigational Site | Denver | Colorado | 80210 | — |
| Pfizer Investigational Site | Largo | Florida | 34640 | — |
| Pfizer Investigational Site | Tampa | Florida | 33613 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30322 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30342 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30349 | — |
| Pfizer Investigational Site | East Point | Georgia | 30223 | — |
| Pfizer Investigational Site | Griffin | Georgia | 30223 | — |
| Pfizer Investigational Site | Morrow | Georgia | 30260 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60612 | — |
| Pfizer Investigational Site | Wheaton | Illinois | 60187 | — |
| Pfizer Investigational Site | Elkhart | Indiana | 46515 | — |
| Pfizer Investigational Site | Mishawaka | Indiana | 46545 | — |
| Pfizer Investigational Site | South Bend | Indiana | 46601 | — |
| Pfizer Investigational Site | South Bend | Indiana | 46617 | — |
| Pfizer Investigational Site | Iowa City | Iowa | 52245 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40207 | — |
| Pfizer Investigational Site | Baltimore | Maryland | 21201 | — |
| Pfizer Investigational Site | Owings Mills | Maryland | 21117 | — |
| Pfizer Investigational Site | Boston | Massachusetts | 02111 | — |
| Pfizer Investigational Site | Golden Valley | Minnesota | 55422 | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | 55421 | — |
| Pfizer Investigational Site | Kansas City | Missouri | 64111 | — |
| Pfizer Investigational Site | Kansas City | Missouri | 64114 | — |
| Pfizer Investigational Site | Warrensburg | Missouri | 64093 | — |
| Pfizer Investigational Site | Concord | New Hampshire | 03301 | — |
| Pfizer Investigational Site | South Plainfield | New Jersey | 07080 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28204 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28210 | — |
| Pfizer Investigational Site | Charlotte | North Carolina | 28260 | — |
| Pfizer Investigational Site | Matthews | North Carolina | 28105 | — |
| Pfizer Investigational Site | Monroe | North Carolina | 28112 | — |
| Pfizer Investigational Site | Portland | Oregon | 97201 | — |
| Pfizer Investigational Site | Portland | Oregon | 97210 | — |
| Pfizer Investigational Site | Wyomissing | Pennsylvania | 19610 | — |
| Pfizer Investigational Site | Charleston | South Carolina | 29412 | — |
| Pfizer Investigational Site | Mt. Pleasant | South Carolina | 29464-3245 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38119 | — |
| Pfizer Investigational Site | Austin | Texas | 78731-4941 | — |
| Pfizer Investigational Site | Galveston | Texas | 77555-1141 | — |
| Pfizer Investigational Site | Houston | Texas | 77030 | — |
| Pfizer Investigational Site | Charlottesville | Virginia | — | — |
| Pfizer Investigational Site | Richmond | Virginia | 23219 | — |
| Pfizer Investigational Site | Richmond | Virginia | 23235 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98431 | — |
| Pfizer Investigational Site | Madison | Wisconsin | 53705 | — |
| Pfizer Investigational Site | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00800267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2021 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00800267 live on ClinicalTrials.gov.